GB Sciences, Inc.
from OTCQB Podcast
GB Sciences (OTCQB: GBLX) is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market. President & Chief Scientific Officer, Andrea Small-Howard, joins us to discuss how the company differentiates itself in the crowded biopharmaceutical field. View Podcast Transcript
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 6 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on May 22, 2023.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.